JPH0273093A - 3-deoxy-d-glycero-d-galacto-2-nonulopyranosonic acid derivative - Google Patents
3-deoxy-d-glycero-d-galacto-2-nonulopyranosonic acid derivativeInfo
- Publication number
- JPH0273093A JPH0273093A JP22612588A JP22612588A JPH0273093A JP H0273093 A JPH0273093 A JP H0273093A JP 22612588 A JP22612588 A JP 22612588A JP 22612588 A JP22612588 A JP 22612588A JP H0273093 A JPH0273093 A JP H0273093A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- added
- formula
- compound expressed
- subjected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- CLRLHXKNIYJWAW-QBTAGHCHSA-N deaminoneuraminic acid Chemical class OC[C@@H](O)[C@@H](O)[C@@H]1OC(O)(C(O)=O)C[C@H](O)[C@H]1O CLRLHXKNIYJWAW-QBTAGHCHSA-N 0.000 title description 2
- 125000003118 aryl group Chemical group 0.000 claims abstract description 7
- 239000002253 acid Substances 0.000 claims abstract description 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 4
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 4
- 150000002367 halogens Chemical class 0.000 claims abstract description 4
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 3
- 150000001340 alkali metals Chemical class 0.000 claims abstract description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 44
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 32
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract description 32
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract description 11
- WFPZPJSADLPSON-UHFFFAOYSA-N dinitrogen tetraoxide Chemical compound [O-][N+](=O)[N+]([O-])=O WFPZPJSADLPSON-UHFFFAOYSA-N 0.000 abstract description 7
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 abstract description 6
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 abstract description 4
- 125000003545 alkoxy group Chemical group 0.000 abstract description 3
- 125000000217 alkyl group Chemical group 0.000 abstract description 3
- 239000007864 aqueous solution Substances 0.000 abstract description 3
- 239000001632 sodium acetate Substances 0.000 abstract description 3
- 235000017281 sodium acetate Nutrition 0.000 abstract description 3
- BLAKAEFIFWAFGH-UHFFFAOYSA-N acetyl acetate;pyridine Chemical compound C1=CC=NC=C1.CC(=O)OC(C)=O BLAKAEFIFWAFGH-UHFFFAOYSA-N 0.000 abstract description 2
- 230000004913 activation Effects 0.000 abstract description 2
- 230000017858 demethylation Effects 0.000 abstract description 2
- 238000010520 demethylation reaction Methods 0.000 abstract description 2
- 238000010438 heat treatment Methods 0.000 abstract description 2
- 210000005036 nerve Anatomy 0.000 abstract description 2
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 abstract 1
- 230000001741 anti-phlogistic effect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000002904 solvent Substances 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 16
- 239000000203 mixture Substances 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- 238000004949 mass spectrometry Methods 0.000 description 12
- 238000000921 elemental analysis Methods 0.000 description 11
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 9
- 238000005160 1H NMR spectroscopy Methods 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 239000003463 adsorbent Substances 0.000 description 8
- 238000001914 filtration Methods 0.000 description 8
- 239000000741 silica gel Substances 0.000 description 8
- 229910002027 silica gel Inorganic materials 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- KARBGKKDOYQAGB-LUWBGTNYSA-N CC(=O)N(N=O)[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO Chemical class CC(=O)N(N=O)[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO KARBGKKDOYQAGB-LUWBGTNYSA-N 0.000 description 7
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 description 7
- 238000004440 column chromatography Methods 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- 239000012230 colorless oil Substances 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 150000004702 methyl esters Chemical class 0.000 description 6
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 5
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- -1 methoxy, ethoxy, propoxy Chemical group 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 3
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002519 immonomodulatory effect Effects 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000002808 molecular sieve Substances 0.000 description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- UBZYKBZMAMTNKW-UHFFFAOYSA-J titanium tetrabromide Chemical compound Br[Ti](Br)(Br)Br UBZYKBZMAMTNKW-UHFFFAOYSA-J 0.000 description 2
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 description 1
- CERZMXAJYMMUDR-QBTAGHCHSA-N 5-amino-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosonic acid Chemical class N[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO CERZMXAJYMMUDR-QBTAGHCHSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 101100004166 Mus musculus Bag4 gene Proteins 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 description 1
- 241000277329 Oncorhynchus keta Species 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 238000005882 aldol condensation reaction Methods 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- CZKMPDNXOGQMFW-UHFFFAOYSA-N chloro(triethyl)germane Chemical compound CC[Ge](Cl)(CC)CC CZKMPDNXOGQMFW-UHFFFAOYSA-N 0.000 description 1
- FSMCJUNYLQOAIM-UQBZCTSOSA-N cholesteryl beta-D-glucoside Chemical class O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FSMCJUNYLQOAIM-UQBZCTSOSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002431 hydrogen Chemical group 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- OKDQKPLMQBXTNH-UHFFFAOYSA-N n,n-dimethyl-2h-pyridin-1-amine Chemical compound CN(C)N1CC=CC=C1 OKDQKPLMQBXTNH-UHFFFAOYSA-N 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229910001958 silver carbonate Inorganic materials 0.000 description 1
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、新規な3−デオキシ−D−グリセロ−D−ガ
ラクト−2−ノヌロビラノソン酸誘導体に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to novel 3-deoxy-D-glycero-D-galacto-2-nonuroviranosonic acid derivatives.
N−アセチル−D−ノイラミン酸は脱糖タンパク質及び
糖脂質中に広く分布している。そして、N−アセチル−
D−ノイラミン酸の2−〇−グリコジル及び2−N−置
換誘導体並びにコレステロールグリコシド等の合成例が
報告されている(Chew、 Pharm、 Bull
、35 (10) 4043−4048 (1987)
)。さらにシアロシルコレステロールについては神経障
害疾患の治療剤として有用であるとの報告がある〔特開
昭62−265229号公報〕。N-acetyl-D-neuraminic acid is widely distributed in deglycosylated proteins and glycolipids. And N-acetyl-
Synthesis examples of 2-0-glycodyl and 2-N-substituted derivatives of D-neuraminic acid and cholesterol glycoside have been reported (Chew, Pharm, Bull
, 35 (10) 4043-4048 (1987)
). Furthermore, it has been reported that sialosylcholesterol is useful as a therapeutic agent for neurological disorders [JP-A-62-265229].
そこで本発明は、神経付活作用、免疫調節作用、抗炎症
作用等を有することが期待されるノヌロピラノソン酸の
新規な誘導体を提供することを目的とする。Therefore, an object of the present invention is to provide a novel derivative of nonulopyranosonic acid that is expected to have nerve activation, immunomodulation, anti-inflammatory effects, and the like.
本発明は、下記−形式で表わされる3−デオキシ−D−
グリセロ−D−ガラクト−2ノヌロピラノソン酸誘導体
に関する。The present invention provides 3-deoxy-D-
This invention relates to glycero-D-galacto-2 nonulopyranosonic acid derivatives.
塩素及び臭素を例示でき、Ct ”” Cbのアルキル
基としてはメチル、エチル、プロピル、ブチル、ペンチ
ル、ヘキシルを挙げることができ、アラアルキル基とし
ては、
m=0〜3)を挙げることができる。Examples include chlorine and bromine, examples of the alkyl group of Ct ``'' Cb include methyl, ethyl, propyl, butyl, pentyl, and hexyl, and examples of the aralkyl group include m = 0 to 3).
以下に本発明の化合物の具体例を示す。Specific examples of the compounds of the present invention are shown below.
(式中R1は水素又はアセチル基を表わし、R2はC1
〜Chのアルコキシ基、コレステニル基、コレスタニル
基又はハロゲンを表わし、R3は水素、CI−Cbのア
ルキル基、了り−ル基、アラアルキル基、アルカリ金属
又はNHa”c表わす)
以下本発明について説明する。(In the formula, R1 represents hydrogen or an acetyl group, and R2 is C1
~Ch represents an alkoxy group, cholestenyl group, cholestanyl group, or halogen; R3 represents hydrogen, a CI-Cb alkyl group, an aryol group, an aralkyl group, an alkali metal, or NHa"c) The present invention will be described below. .
本発明の化合物を表わす一般式中、CI” Cbのアル
コキシ基としてはメトキシ、エトキシ、プロポキシ等を
挙げることができ、ハロゲンとしては本発明の化合物の
製造法をスキームに従って説明する。In the general formula representing the compound of the present invention, examples of the alkoxy group of CI''Cb include methoxy, ethoxy, propoxy, etc., and examples of the halogen include the method for producing the compound of the present invention according to the scheme.
金戒迭↓(スキーム1−1〜l−3)
N−アセチル−D−ノイラミン酸(2)から化合物(3
)、(4)、(5)及び(7)を逐次合成することがで
きる。Jin Kaiyeon↓ (Schemes 1-1 to l-3) From N-acetyl-D-neuraminic acid (2) to compound (3
), (4), (5) and (7) can be synthesized sequentially.
N−アセチル−D−ノイラミン酸(2)は市販されてお
り既知の方法〔例えばダウエックス−50(H”)の存
在下メタノール処理してメチルエステル化し、次いでA
ctOPy(無水酢酸−ピリジン)処理してヘキサアセ
チル化する方法〕により化合物(3)を得ることができ
る。N-acetyl-D-neuraminic acid (2) is commercially available and is methyl esterified by a known method [for example, treated with methanol in the presence of DOWEX-50 (H''), then methyl esterified with A
Compound (3) can be obtained by a method of hexaacetylation by treatment with ctOPy (acetic anhydride-pyridine).
化合物(3)を酢酸ナトリウムの存在下酢酸中、四酸化
二窒素と反応させると黄色のN−アセチル−N−ニトロ
ソノイラミン酸誘導体(4)が得られる。さらに化合物
(4)を四塩化炭素中で加熱還流すると黄色は消失して
、化合物(5)及び副生物(6)が得られる。化合物(
7)は化合物(5)をK z CO3−メタノール処理
により脱保護することにより得ることができる。尚、化
合物(7)をさらに0.1N NaOH処理及びCF
3COOH水溶液中で加熱して、脱メチルすると化合物
(1)とすることができる。When compound (3) is reacted with dinitrogen tetroxide in acetic acid in the presence of sodium acetate, a yellow N-acetyl-N-nitrosoneuraminic acid derivative (4) is obtained. Further, when compound (4) is heated and refluxed in carbon tetrachloride, the yellow color disappears and compound (5) and by-product (6) are obtained. Compound(
7) can be obtained by deprotecting compound (5) by K z CO3-methanol treatment. In addition, compound (7) was further treated with 0.1N NaOH and CF
Compound (1) can be obtained by demethylation by heating in a 3COOH aqueous solution.
又、化合物(7)をIN NaOHで処理し、次いで
C!3zCO3、BnBr (臭化ベンジル)で処理
することによりベンジルエステル(14)を得ることが
できる。Alternatively, compound (7) was treated with IN NaOH and then C! Benzyl ester (14) can be obtained by treatment with 3zCO3, BnBr (benzyl bromide).
スキーム
p
115−118℃
wp
59−61℃
合成法2(スキーム2−1〜2−2)
D−マンノースから3−デオキシ−D−グリセロ−D−
ガラクト−2−ノヌロビラノソン酸(1)を経由して化
合物(8)、(9)、(10)、(11)、(12)、
(13)、(15) 、 (16)、(17)及び(1
8)を合成することができる。Scheme p 115-118°C wp 59-61°C Synthesis method 2 (Schemes 2-1 to 2-2) D-mannose to 3-deoxy-D-glycero-D-
Compounds (8), (9), (10), (11), (12), via galacto-2-nonuroviranosonic acid (1),
(13), (15), (16), (17) and (1
8) can be synthesized.
尚化合物(1)は、シロサケ(釦並悲U薊旦ke ta
)卵受精時洗浄水の凍結乾燥粉末より、イオン交換クロ
マトグラフィー(ダウエックス−1(ギ酸エステル)、
2Mギ酸溶出)等を用いて得ることもできる。又、D−
マンノースからの化合物(1)の合成は、オキザロ酢酸
とD−マンノーースを水溶液中塩基性条件下(炭酸ナト
リウムおよび水酸化ナトリウム、ρB11)アルドール
縮合させ、さらに脱炭酸をすることにより行うことがで
きる。Compound (1) is a type of chum salmon (
) Ion-exchange chromatography (Dowex-1 (formate ester),
It can also be obtained using 2M formic acid elution). Also, D-
Compound (1) can be synthesized from mannose by aldol condensation of oxaloacetic acid and D-mannose in an aqueous solution under basic conditions (sodium carbonate and sodium hydroxide, ρB11), followed by decarboxylation.
化合物(1)は、例えばダウエックス−50(H”)の
存在下メタノールで処理してメチルエステル(8)とし
、さらに(8)をAC!0−PV処理してヘキサアセチ
ル化体(9)を得ることができる。Compound (1) is, for example, treated with methanol in the presence of DOWEX-50 (H'') to give methyl ester (8), and then (8) is further treated with AC!0-PV to give hexaacetylated compound (9). can be obtained.
化合物(1)はAczO−Py処理し、次いで生成物を
Cs、CO,と反応させ次いでBnBrと反応させるこ
とにより化合物(10)とすることができる。化合物(
lO)はTiBr、で臭素化することにより化合物(1
1)とすることができる。Compound (1) can be converted into compound (10) by treating with AczO-Py, and then reacting the product with Cs, CO, and then with BnBr. Compound(
1O) is brominated with TiBr, to form the compound (1
1).
化合物(11)をAgzCOiの存在下メタノールで処
理するとメチルエステル(12)を得ることができる。Methyl ester (12) can be obtained by treating compound (11) with methanol in the presence of AgzCOi.
メチルエステル(12)を脱Ac処理(例えば0.01
NNaOH処理)すると化合物(13)を得ることがで
きる。Methyl ester (12) is subjected to Ac removal treatment (e.g. 0.01
(NNaOH treatment), compound (13) can be obtained.
又化合物(11)をA g OS O! CFの存在下
コレステロールと反応させることにより化合物(15)
(α体)及び(16)(β体)を得ることができ、化合
物(15)、(16)を脱保護処理(例えばlNNaO
H処理)することにより化合物(17)(α体)及び(
1B)(β体)を得る。Also, compound (11) is A g OS O! Compound (15) by reacting with cholesterol in the presence of CF
(α-isomer) and (16) (β-isomer) can be obtained, and compounds (15) and (16) can be deprotected (for example, INNaO
H treatment), compound (17) (α form) and (
1B) (β form) is obtained.
本発明の新規な3−デオキシ−D−グリセロD−ガラク
トー2−ノヌロピラノソン酸誘導体は、神経付活作用、
免疫調節作用、抗炎症作用等を有することが期待され、
種々の医薬としての利用が期待される。The novel 3-deoxy-D-glycero-D-galacto-2-nonulopyranosonic acid derivatives of the present invention have neurostimulatory effects,
It is expected to have immunomodulatory effects, anti-inflammatory effects, etc.
It is expected to be used as a variety of medicines.
以下本発明を実施例によりさらに説明する。 The present invention will be further explained below with reference to Examples.
参考例1 (D−マンノース−(1)〕〕D−マンノ
ース27.03 g (150mmoりと無水炭酸ナ
トリウム6.36 g (60mmol)を水3211
1に溶解し、これにオキザロ酢酸6.61g(50mm
ol)を少量ずつ加えた。次いで10M水酸化ナトリウ
ム溶液を用いて反応液をpH11に調製し、室温で2時
間攪拌した。反応後、Dowex −50(H”型)を
加えて反応液をpH1〜2にし、室温にて攪拌を続けた
。30分後、攪拌を止めDowex−50を濾過して除
き、濾液をアンモニア水を用いて中和し、これをDow
ex −1(ギ酸型)を用いたイオン交換クロマトグラ
フィーにかけ、0.3Mギ酸水溶液で溶出した。溶出液
は微圧下溶媒を留去した後、アンモニア水を用いて中和
、溶解し、再び微圧下溶媒を留去して無色油状物を得た
。Reference Example 1 (D-Mannose-(1)) 27.03 g (150 mmol) of D-mannose and 6.36 g (60 mmol) of anhydrous sodium carbonate were mixed with 3211 g of water.
1 and 6.61 g of oxaloacetic acid (50 mm
ol) was added little by little. The reaction solution was then adjusted to pH 11 using 10M sodium hydroxide solution and stirred at room temperature for 2 hours. After the reaction, Dowex-50 (H" type) was added to adjust the reaction solution to pH 1-2, and stirring was continued at room temperature. After 30 minutes, stirring was stopped and Dowex-50 was removed by filtration, and the filtrate was diluted with aqueous ammonia. Neutralize using Dow
It was subjected to ion exchange chromatography using ex-1 (formic acid type) and eluted with a 0.3M aqueous formic acid solution. After distilling off the solvent under slight pressure, the eluate was neutralized and dissolved using aqueous ammonia, and the solvent was distilled off again under slight pressure to obtain a colorless oil.
収量5.6g 収率39%
実施例1 ((1)−(10))
ピリジン54mlと無水酢酸54allの混合液中に化
合物(1) 3.9 g (13,7mmol)とN、
N−ジメチルアミノピリジン67mgを加え室温で攪
拌した。24時間後、攪拌を止め、クロロホルム390
mlを加え5℃まで冷却し、IN塩酸140tanで2
回洗浄した。有機層は無水硫酸マグネシウムで乾燥し、
微圧下溶媒を留去した。次に残渣をN、N−ジメチルホ
ルムアミド5mj!と水5mlの混合液に溶解し、これ
に炭酸セシウム1.53 g(4,7mmol )を加
え撹拌し、発泡が止ったら微圧下溶媒を留去した。残渣
はN、 N−ジメチルホルムアミド20ralに溶解し
、これに臭化ベンジル1、9 g (1,1mmol)
を加え室温にて撹拌した。2時間後、反応液に水100
tallを加え、酢酸エチル30mlで3回抽出し、有
機層を合わせて炭酸水素ナトリウム水溶液と食塩水で洗
浄した。有機層は無水硫酸マグネシウムを用いて乾燥し
、微圧下溶媒を留去した後、シリカゲルを吸着剤とした
カラムクロマトグラフィーにかけ目的物を無色油状物と
して得た。Yield: 5.6 g Yield: 39% Example 1 ((1)-(10)) In a mixed solution of 54 ml of pyridine and 54 all of acetic anhydride, 3.9 g (13.7 mmol) of compound (1) and N,
67 mg of N-dimethylaminopyridine was added and stirred at room temperature. After 24 hours, stop stirring and add 390 ml of chloroform.
ml, cooled to 5°C, and diluted with 140 tan of IN hydrochloric acid.
Washed twice. The organic layer was dried over anhydrous magnesium sulfate;
The solvent was distilled off under slight pressure. Next, the residue was treated with 5 mj of N,N-dimethylformamide. 1.53 g (4.7 mmol) of cesium carbonate was added thereto and stirred. When foaming stopped, the solvent was distilled off under slight pressure. The residue was dissolved in 20 ral of N,N-dimethylformamide, and 1.9 g (1.1 mmol) of benzyl bromide was added thereto.
was added and stirred at room temperature. After 2 hours, add 100% water to the reaction solution.
The mixture was extracted with 30 ml of ethyl acetate three times, and the organic layers were combined and washed with an aqueous sodium bicarbonate solution and brine. The organic layer was dried using anhydrous magnesium sulfate, and after distilling off the solvent under slight pressure, it was subjected to column chromatography using silica gel as an adsorbent to obtain the desired product as a colorless oil.
収量4.05g 収率47%
「αJ 25−17.4°(cm1. C)IC1i)
。Yield 4.05g Yield 47% "αJ 25-17.4° (cm1.C)IC1i)
.
質量分析(El) mム550 (M”−59)。Mass spectrometry (El) mm 550 (M''-59).
元素分析(Cz。H3401S) : C; 55.
08. H; 5.61゜測定値: C; 55.29
. H; 5.78゜IRI/にBr cva−’ 2
960.1745゜’HNMR(300M)lz、 C
DCJa) 1.99.2.01.2.02゜2.02
.2.09.2.11 (18H,5x6)、 2.0
8 (IH,dd。Elemental analysis (Cz.H3401S): C; 55.
08. H; 5.61° Measured value: C; 55.29
.. H; 5.78゜IRI/to Br cva-' 2
960.1745゜'HNMR(300M)lz, C
DCJa) 1.99.2.01.2.02゜2.02
.. 2.09.2.11 (18H, 5x6), 2.0
8 (IH, dd.
J=13.5及び11.4 Hz、 3−Hax)、
2.62 (IH,dd。J = 13.5 and 11.4 Hz, 3-Hax),
2.62 (IH, dd.
J=13.5及び5.2 Hz、 3−Heq)、 4
.15 (IH,dd。J=13.5 and 5.2 Hz, 3-Heq), 4
.. 15 (IH, dd.
J=12.5及び5.9 Hz、 9−H)、 4.1
9 (18,dd。J=12.5 and 5.9 Hz, 9-H), 4.1
9 (18, dd.
J=10.2及び2.2 Hz、 6−H)、 4.4
0 (18,dd。J=10.2 and 2.2 Hz, 6-H), 4.4
0 (18, dd.
J=12.5及び2.6 Hz、 9’ −H)、 4
.96 (IH,t。J=12.5 and 2.6 Hz, 9'-H), 4
.. 96 (IH, t.
J=10.2及び9.8 Hz、 5−H)、 5.1
6 (IH,m、 8−H)、 5.15.5.23
(2H,dx2. J=r2.OHz、 CHtPh)
。J=10.2 and 9.8 Hz, 5-H), 5.1
6 (IH, m, 8-H), 5.15.5.23
(2H, dx2. J=r2.OHz, CHtPh)
.
5.26 (1)1. m、 4−H)、 5.39
(1B、 dd、 J=6.1及び2.2 Hz、 7
H)、 7.35 (5H,m、芳香族H)。5.26 (1)1. m, 4-H), 5.39
(1B, dd, J=6.1 and 2.2 Hz, 7
H), 7.35 (5H,m, aromatic H).
実施例2 ((10)−(11))
化合物(10) 2.0 g (3,3mmol)を無
水ジクロロメタン103mlに?8解し、これにモレキ
ュラーシーブス4Aを2.0g加え室温で撹拌した。Example 2 ((10)-(11)) 2.0 g (3.3 mmol) of compound (10) was added to 103 ml of anhydrous dichloromethane. 8, 2.0 g of Molecular Sieves 4A was added thereto, and the mixture was stirred at room temperature.
−時間後、これを5℃に冷却し臭化チタン4.85g
(13mmol)を加え室温で16時間攪拌した。- hours later, it was cooled to 5°C and 4.85g of titanium bromide was added.
(13 mmol) was added and stirred at room temperature for 16 hours.
反応後、無水酢酸ナトリウム8.9gとアセトニトリル
5711を加え室温で30分間攪拌し、過剰の臭化チタ
ンを分解し、さらにトルエン268allを加えて氷水
中で冷却しながら攪拌した。30分間撹拌後、不溶物を
濾過して除き、濾液より微圧下溶媒を留去して目的物を
無色油状物として得た。After the reaction, 8.9 g of anhydrous sodium acetate and 5711 l of acetonitrile were added and stirred at room temperature for 30 minutes to decompose excess titanium bromide. Further, 268 all of toluene was added and stirred while cooling in ice water. After stirring for 30 minutes, insoluble matter was removed by filtration, and the solvent was distilled off from the filtrate under slight pressure to obtain the desired product as a colorless oil.
収量 2.07 g 収率100%rα」25 5
9.0 ” (cm0.6. CHCl!り。Yield 2.07 g Yield 100% rα”25 5
9.0” (cm0.6. CHCl!ri.
質量分析(El) +aムロ31.633 (M” )
。Mass spectrometry (El) +a Muro 31.633 (M”)
.
IRνにBr cm−’ 34B0. 2970.
1750゜’H−NMR(300MHz、 CDCj
! 3) 2.02.2.05゜2.06.2.08.
2.09 C3Hx5. sx5. C0CH1)、
2.23<IN。IRν to Br cm-' 34B0. 2970.
1750°'H-NMR (300MHz, CDCj
! 3) 2.02.2.05゜2.06.2.08.
2.09 C3Hx5. sx5. C0CH1),
2.23<IN.
dd、 J=14.2及び11.2 tlz、 3−8
ax)、 2.99 (IH。dd, J=14.2 and 11.2 tlz, 3-8
ax), 2.99 (IH.
dd、 J=14.2及び5.0 Hz、 3−11e
q)、 4.12 (LH。dd, J=14.2 and 5.0 Hz, 3-11e
q), 4.12 (LH.
dd、 J=12.8及び4.9 Hz、 9−H)、
4.36 (IH,dd。dd, J=12.8 and 4.9 Hz, 9-H),
4.36 (IH, dd.
J=12.8及び2.4 Hz、 9’ −H)、 4
.44 (IH,dd。J=12.8 and 2.4 Hz, 9'-H), 4
.. 44 (IH, dd.
J=10.4及び2.1 Hz、 6−H)、 4.9
9 (IH,t、 J=10.0 Hz、 5 H
)、 5.23 (IH,m、 8 H)、
5.26゜5.38 (2H,dx2. J=1
2.0 Hz、 CHzPh)、 5.50 (
IH。J=10.4 and 2.1 Hz, 6-H), 4.9
9 (IH, t, J=10.0 Hz, 5 H
), 5.23 (IH, m, 8 H),
5.26°5.38 (2H, dx2. J=1
2.0 Hz, CHzPh), 5.50 (
IH.
m、 4−)1)、 5.51 (IH,dd、 J=
8.4及び2.1 Hz。m, 4-)1), 5.51 (IH, dd, J=
8.4 and 2.1 Hz.
?−H)、 7.40 (5H,m、芳香族11)。? -H), 7.40 (5H, m, aromatic 11).
実施例3((11)→(12))
メタノール10m1tに化合物(II)1.03g(1
,63mmol)とモレキュラーシーブス4A1.03
g、炭酸銀903mgを加え室温で30分間攪拌した。Example 3 ((11) → (12)) Compound (II) 1.03g (1
, 63 mmol) and molecular sieves 4A1.03
g and 903 mg of silver carbonate were added thereto, and the mixture was stirred at room temperature for 30 minutes.
反応後、不溶物を濾過して除き、濾液より微圧下溶媒を
留去した後、シリカゲルを吸着剤としだカラムクロマト
グラフィーにかけ目的物を無色油状物として得た。After the reaction, the insoluble matter was removed by filtration, and the filtrate was distilled off under slight pressure to remove the solvent, followed by column chromatography using silica gel as an adsorbent to obtain the desired product as a colorless oil.
収量712mg 収率75%
[αJ 25−24.0°(cm1. C11(1,)
。Yield 712 mg Yield 75% [αJ 25-24.0° (cm1. C11(1,)
.
質量分析(El) m/z 582 (M”)。Mass spectrometry (El) m/z 582 (M”).
元素分析(CzJ340+4) : C; 55.6
7、 )l; 5.8B。Elemental analysis (CzJ340+4): C; 55.6
7, )l; 5.8B.
実測値: C; 55.90. H,5,93゜IR
vKBr cm−’ 2980,2950,1750
゜’HNMR(300MHz、 CDCj!s)
1.89. (1)1. t、 J=12.5
Hz、 3=Hax)、 1.99. 1.99.
2.02. 2.09゜2.16 (15H,sx
5. C0Cth)、 2.70 (1)1.
dd、 J=12.7及び4.2 Hz、 3−1
1eq)、 3.23 (3H,s、 CHz)。Actual value: C; 55.90. H, 5, 93°IR
vKBr cm-' 2980, 2950, 1750
゜'HNMR (300MHz, CDCj!s)
1.89. (1)1. t, J=12.5
Hz, 3=Hax), 1.99. 1.99.
2.02. 2.09゜2.16 (15H, sx
5. C0Cth), 2.70 (1)1.
dd, J=12.7 and 4.2 Hz, 3-1
1eq), 3.23 (3H,s, CHz).
4.12 (IH,dd、 J=12.5及び4.6
Hz、 9−H)。4.12 (IH, dd, J=12.5 and 4.6
Hz, 9-H).
4.18 (IH,dd、 J=10.0及び2.2
Hz、 6−H)。4.18 (IH, dd, J=10.0 and 2.2
Hz, 6-H).
4.26 (IH,dd、 J=12.5及び2.4
tlz、 9 ’ −H)。4.26 (IH, dd, J=12.5 and 2.4
tlz, 9′-H).
4.86 (IH,t、 J=9.511z、
5−tl)、 4.89 (III、 m。4.86 (IH, t, J=9.511z,
5-tl), 4.89 (III, m.
4−H)、 5.20. 5.25 (211,d
x2. J=12.0 Hz。4-H), 5.20. 5.25 (211,d
x2. J = 12.0 Hz.
CHgPh)、 5.34 (LH,dd、 J=9.
1及び2.2 Hz。CHgPh), 5.34 (LH, dd, J=9.
1 and 2.2 Hz.
7−H)、 5.42 (IH,m、 8−H)
。7-H), 5.42 (IH, m, 8-H)
.
実施例4 ((12)−(13))
メタノール15mlに化合物(12)300mg(0,
515mmol)を溶解し、その中へ0.01N水酸化
ナトリウム水溶液15mj2を加え室温で2時間攪拌し
た。反応後、水30m1tを加え、Dowex−50(
H”型)を用いて中和し、Dowex −50を濾過し
て除く。濾液は微圧下溶媒を留去した後、再結晶を行な
い目的物を無色針状晶として得た。Example 4 ((12)-(13)) 300 mg of compound (12) (0,
515 mmol) was dissolved therein, 15 mj2 of a 0.01N aqueous sodium hydroxide solution was added thereto, and the mixture was stirred at room temperature for 2 hours. After the reaction, 30 ml of water was added and Dowex-50 (
Dowex-50 was removed by filtration. After distilling off the solvent under slight pressure, the filtrate was recrystallized to obtain the desired product as colorless needle-like crystals.
収11it130mg 収率67%mp97−99
℃。Yield 11it130mg Yield 67%mp97-99
℃.
[αJ 27−38.4°(cm0.17. MeOH
)。[αJ 27-38.4° (cm0.17. MeOH
).
質量分析(El) rn/z 341 (M” 31
)。Mass spectrometry (El) rn/z 341 (M” 31
).
元素分析(C+JzaOq・LO) : C; 52.
30. H;6.7L実測値: C; 52.42.
)1.6.49゜IR1(Br cm−’ 3510.
3330.2950.2900゜1720゜
’ H−NMRのデータは表1に示す。Elemental analysis (C+JzaOq・LO): C; 52.
30. H; 6.7L Actual value: C; 52.42.
) 1.6.49°IR1 (Br cm-' 3510.
3330.2950.2900°1720°' H-NMR data are shown in Table 1.
実施例5 ((7)−(14))
化合物(7)55mgをIN水酸化ナトリウム水溶液に
溶解し室温で2時間攪拌した。次にDowex−50(
H”型)を用いて反応液を中和し、濾過した後、微圧下
溶媒を留去した。残渣はN、N−ジメチルホルムアミド
5mlに溶解し、その中へ臭化ベンジル57mgを加え
室温で2時間攪拌した。Example 5 ((7)-(14)) 55 mg of compound (7) was dissolved in IN aqueous sodium hydroxide solution and stirred at room temperature for 2 hours. Next, Dowex-50 (
After neutralizing the reaction solution using a diluted solution (H" type) and filtering, the solvent was distilled off under slight pressure. The residue was dissolved in 5 ml of N,N-dimethylformamide, and 57 mg of benzyl bromide was added thereto, and the mixture was stirred at room temperature. Stirred for 2 hours.
反応後、不溶物を濾過して除き、濾液より微圧下溶媒を
留去して、残渣をシリカゲルを吸着剤としたカラムクロ
マトグラフィーにかけ目的物を無色油状物として得た。After the reaction, insoluble matter was removed by filtration, the solvent was distilled off from the filtrate under slight pressure, and the residue was subjected to column chromatography using silica gel as an adsorbent to obtain the desired product as a colorless oil.
収量40mg 収率58%
「αJ 26−37.9 ” (cm0.33. Me
O)I)。Yield: 40 mg Yield: 58% "αJ 26-37.9" (cm0.33.Me
O)I).
質量分析(El) m/z 340 (M” 32)
元素分析(C+、HzaOq・HzO) : C: 5
2.30. H; 6,71゜実測値: C; 52
.71. H; 6.58゜IRvKBr cm−’
3300.2925.1725゜’ H−NMRのデー
タは表1に示す。Mass spectrometry (El) m/z 340 (M” 32)
Elemental analysis (C+, HzaOq・HzO): C: 5
2.30. H; 6,71°Actual measurement: C; 52
.. 71. H; 6.58゜IRvKBr cm-'
3300.2925.1725°' H-NMR data are shown in Table 1.
実施例6 ((11)−(15)、(16) )ジクロ
ロメタン30mlにコレステロール770tag (2
mmol)を溶解し、その中ヘモレキュラーシーブス4
A770mgを加え室温にて一時間撹拌した。次にこの
中へ化合物(11) 1.5g (2,4mmo l
)とトリフルオロメタンスルホン酸銀0.51gを加え
遮光上室温で一日攪拌した。反応後、不溶物を濾過して
除き、濾液より微圧下溶媒を留去し、残渣をシリカゲル
を吸着剤とするクロマトグラフィーにかけ目的物を無色
油状物として得た。Example 6 ((11)-(15), (16)) 770 tags of cholesterol in 30 ml of dichloromethane (2
mmol) in which hemolecular sieves 4
770 mg of A was added and stirred at room temperature for 1 hour. Next, 1.5 g (2.4 mmol) of compound (11) was added into this.
) and 0.51 g of silver trifluoromethanesulfonate were added, and the mixture was stirred for one day at room temperature while shielded from light. After the reaction, insoluble materials were removed by filtration, the solvent was distilled off from the filtrate under slight pressure, and the residue was subjected to chromatography using silica gel as an adsorbent to obtain the desired product as a colorless oil.
副生物490mg 副生物43%α体(1
5): r αJ 25−37.4°(cm1. C
HCj! :l)。By-product 490mg By-product 43% α form (1
5): r αJ 25-37.4° (cm1.C
HCj! :l).
質量分析(El) mム859 (M”80)、元素分
析(CsJtaO+4): C; 67.78. H;
8.37.実測値:C; 67.82.H; 8
.28゜IRvKBr c−m−’ 2940.174
5. ’H−NMRのデーは表2に示す。Mass spectrometry (El) mm859 (M”80), elemental analysis (CsJtaO+4): C; 67.78.H;
8.37. Actual value: C; 67.82. H; 8
.. 28゜IRvKBr cm-' 2940.174
5. 'H-NMR data is shown in Table 2.
β体(16): rαJ 25 35.6 ” (c
m1. CHCl3)。β body (16): rαJ 25 35.6” (c
m1. CHCl3).
質量分析(El) m/z 937 (M”)元素分析
(CsJ、aO□): c; 67.78. H;
8.37゜実測値: C; 67.67、 H;8.
17゜IRvKBr cm−” 1940.1750.
’H−NMRのデーは表2に示す。Mass spectrometry (El) m/z 937 (M”) Elemental analysis (CsJ, aO□): c; 67.78. H;
8.37° Actual measurement: C; 67.67, H; 8.
17°IRvKBr cm-” 1940.1750.
'H-NMR data is shown in Table 2.
化合物
−Wax
−Heq
−H
−H
−H
−H
−H
−H
−H
CR3
nzph
芳香族H
表1
1.59
2.49
3.75
3.37
3.71
3.61
3.69−3.73
3.53
3.70
3.71
5.22
7.29−7.39
’H=NMR
(DZO)
t、 J=12.0Hz
dd、 J=12.4. 4.0Hz■
t、 J=9.5Hz
■
bro−d、 J=10.0)1z
曽
dd、 J=12.0.4.9Hz
鋼
nd
1.61
2.23
3.85
3.45
3.75
3.69
3.75
3.58
3.74
3.10
5.18.5.25
7.32−7.39
MHz 、 δPPM)
IH,t、 J=12.1Hz
IH,dd、 J=13.0.5.0HzLH,dd
d、 J=11.4. 9.5. 5.0Hz1B、
t、 J=9.5Hz
IH,dd、 J=9.5. 1.0Hz1B、 dd
、 J=10.0. 1.0Hz1B、 m
LH,dd、 J=12.0.5.4Hz18、
m
3H,5
IHX2.dX2
50、 ra
化合物
KDN基
3−8ax 1.90
3−Heq 2.72
4−8 4.89
5−H4,84
6−H4,13
?−85,31
8−H5,35
9−H4,1B
9−H4,30
(COCH3) s 1.98
1.99
2.01
2.09
2.14
CHzPh 5.17.5.24
芳香族8 7.30−7.40
コレステロール基
3−H3,46−3,57
18−CH0,65
19−CH0,95
表1
’NMR(CDCj!3) (300?IHz、
δPPM)dd、 J=13.0. 11.6Hzdd
、 J=13.0.4.5Hz
ddd、 J−11,6,9,5,4,5Hzt、 J
=10.0Hz
dd、 J=10.0. 1.9Hz
dd、 J=8.0.1.9Hz
ddd、 J=8.0.4.6.2.2Hzdd、 J
=12.5.4.6)12
dd、 J=12.5.2.2Hz
3uxs、5X5
1)IX2. dX2. J=12.0Hz5H,r
a
18、 ra
IH,s
lH+ s
1.79
2.59
5.30
4.86
4.24
4.21
1.79
1.98
1.99
2.09
5.15. 5.26
7.30−7.40
dd、 J=13.0. 11.6Hzdd、 J=1
3.0.5.2Hz
ddd、 J=11.6.9.5.5.2Hzt、
J=lO,0Hz
dd、 J=10.0.2.2Hz
dd、 J=3.5.2.2Hz
ddd、 J=7.4.3.5.2.IHzdd、 J
=12.5.7.4Hz
dd、 J=12.5.2.1Hz
3HX5,5X5
1HX2. dX2. J=12.1Hz5H,cm
3.46−3.58 18. m
O,663B、 s
O,963H,s
実施例? ((15)、(16)→(17)、(18)
)メタノール10valに化合物(15)、(16)
50mgを溶解し、これにIN水酸化ナトリウム水溶液
10mlを加え室温で3時間攪拌した。反応後、水を1
0tel加え、[)owex −50(H”型)を用い
て中和し、濾過してDowex −50を除き、濾液を
凍結乾燥して目的物を白色粉末として得た。Compound -Wax -Heq -H -H -H -H -H -H -H CR3 nzph Aromatic H Table 1 1.59 2.49 3.75 3.37 3.71 3.61 3.69-3. 73 3.53 3.70 3.71 5.22 7.29-7.39 'H=NMR (DZO) t, J=12.0Hz dd, J=12.4. 4.0Hz ■ t, J=9.5Hz ■ bro-d, J=10.0)1z sodd, J=12.0.4.9Hz Steel nd 1.61 2.23 3.85 3.45 3 .75 3.69 3.75 3.58 3.74 3.10 5.18.5.25 7.32-7.39 MHz, δPPM) IH, t, J=12.1Hz IH, dd, J= 13.0.5.0HzLH,dd
d, J=11.4. 9.5. 5.0Hz1B,
t, J=9.5Hz IH, dd, J=9.5. 1.0Hz1B, dd
, J=10.0. 1.0Hz1B, m LH, dd, J=12.0.5.4Hz18,
m 3H,5 IHX2. dX2 50, ra Compound KDN group 3-8ax 1.90 3-Heq 2.72 4-8 4.89 5-H4,84 6-H4,13 ? -85,31 8-H5,35 9-H4,1B 9-H4,30 (COCH3) s 1.98 1.99 2.01 2.09 2.14 CHzPh 5.17.5.24 Aromatic 8 7 .30-7.40 Cholesterol group 3-H3,46-3,57 18-CH0,65 19-CH0,95 Table 1 'NMR (CDCj!3) (300?IHz,
δPPM)dd, J=13.0. 11.6Hzdd
, J=13.0.4.5Hz ddd, J-11,6,9,5,4,5Hzt, J
=10.0Hz dd, J=10.0. 1.9Hz dd, J=8.0.1.9Hz ddd, J=8.0.4.6.2.2Hzdd, J
=12.5.4.6) 12 dd, J=12.5.2.2Hz 3uxs, 5X5 1) IX2. dX2. J=12.0Hz5H, r
a 18, ra IH,s lH+ s 1.79 2.59 5.30 4.86 4.24 4.21 1.79 1.98 1.99 2.09 5.15. 5.26 7.30-7.40 dd, J=13.0. 11.6Hzdd, J=1
3.0.5.2Hz ddd, J=11.6.9.5.5.2Hzt,
J=lO,0Hz dd, J=10.0.2.2Hz dd, J=3.5.2.2Hz ddd, J=7.4.3.5.2. IHzdd, J
=12.5.7.4Hz dd, J=12.5.2.1Hz 3HX5,5X5 1HX2. dX2. J=12.1Hz5H, cm 3.46-3.58 18. m O,663B, s O,963H,s Example? ((15), (16) → (17), (18)
) Compounds (15), (16) in 10 val of methanol
50 mg was dissolved, 10 ml of IN aqueous sodium hydroxide solution was added thereto, and the mixture was stirred at room temperature for 3 hours. After the reaction, add 1 portion of water
The mixture was neutralized using [)owex-50 (H'' type), filtered to remove Dowex-50, and the filtrate was lyophilized to obtain the desired product as a white powder.
α体(17): rcxJ27−36.7°(cm0
.42. MeOH)。α body (17): rcxJ27-36.7° (cm0
.. 42. MeOH).
質量分析(FD) m/z 859 (M”)。Mass spectrometry (FD) m/z 859 (M”).
元素分析(CsJ6+0Ja): C; 65.53.
H; 9.16゜実測値: C; 65.42. H
;9.21゜IRνKBr c+w−’ 340.0
. 2940. 1?20゜’H−NMR(300Mn
2. CDzOD) 0.70−2.45 (4
5H,m。Elemental analysis (CsJ6+0Ja): C; 65.53.
H; 9.16° Actual measurement: C; 65.42. H
;9.21゜IRνKBr c+w-' 340.0
.. 2940. 1?20゜'H-NMR (300Mn
2. CDzOD) 0.70-2.45 (4
5H, m.
コレステロール) 2.62 (1)1. dd、
J=12.7.4.2Hz、 3 Heq)
3.45−3.90 (7H,ta、 4−5 6
7−8 9−9’ −H)β体(1B): raJ
25−36.7°(c = 0.42. MeOH)
。Cholesterol) 2.62 (1)1. dd,
J=12.7.4.2Hz, 3 Heq) 3.45-3.90 (7H, ta, 4-5 6
7-8 9-9' -H) β form (1B): raJ
25-36.7° (c = 0.42.MeOH)
.
質量分析(FD) ts/z 659 (M”)。Mass spectrometry (FD) ts/z 659 (M”).
元素分析(Cz、l+、、01Na): C; 65.
53. H; 9.16゜実測値: C; 65.0
5. H; 9.38゜IRνKBr cm−’ 3
400.2940.1720゜’H−NMR(300M
n2. CD30D) 0.70 2.30 (
45H。Elemental analysis (Cz, l+, 01Na): C; 65.
53. H; 9.16°Actual measurement: C; 65.0
5. H; 9.38゜IRνKBr cm-' 3
400.2940.1720゜'H-NMR (300M
n2. CD30D) 0.70 2.30 (
45H.
鋼、コレステロール) 2.37 (IH,dd、
J=12.9゜4.8 Hz、 3−11eq)
3.40−3.95 (7H,m、 4−5−6−
7−8−9−9’ −II)考例2
氷水(,30mj!りにION NaOHを加えpH
10,0(pHメーター)とし、よく攪拌しながら水冷
下オキザロ酢酸(5,0g)とION NaOHをp
H10を保つように少しずつ加え、その後D−マンノー
ス(20,5g)を−度に加え1 ON NaOHでp
H11,0に合わせ室温で2時間攪拌した。Dowex
50W−X8 (Hつを用いてpl+6.0に合わせた
のち無水塩化ニッケルとして(0,05g)を加え、5
0〜60℃で1時間加熱攪拌した。溶液のpHは口ow
ex 50 W −X 8 (H” )を適宜加えるこ
とによりpH6,0に維持した。樹脂を濾去後凍結乾燥
により濃縮し、Dowex 1−X 8 (HCO
z−)のカラムを用い、水、0.2N HCO□Hで
順次溶出して精製し、凍結乾燥により無色泡状の化合物
(1)を得た。収量7.04g、収率69%。1のアン
モニウム塩の300MH2’H−NMRより1は3−デ
オキシ−D−グリセロ−β−り一タロー2−ノイラミン
酸(20)との約4.3:1の混合物であった。steel, cholesterol) 2.37 (IH, dd,
J=12.9°4.8 Hz, 3-11eq) 3.40-3.95 (7H, m, 4-5-6-
7-8-9-9'-II) Example 2 Add ION NaOH to ice water (30 mj!) and adjust the pH.
The pH was adjusted to 10.0 (pH meter), and oxaloacetic acid (5.0 g) and ION NaOH were added under water cooling while stirring well.
Add H10 little by little, then add D-mannose (20.5g) and dilute with 1ON NaOH.
The mixture was adjusted to H11.0 and stirred at room temperature for 2 hours. Dowex
After adjusting the PL to +6.0 using 50W-X8 (H), add (0.05g) as anhydrous nickel chloride,
The mixture was heated and stirred at 0 to 60°C for 1 hour. The pH of the solution is
The pH was maintained at 6.0 by appropriately adding ex 50 W -X 8 (H"). The resin was filtered off, concentrated by freeze-drying, and Dowex 1-X 8 (H")
The product was purified using a column of Z-), sequentially eluted with water and 0.2N HCO□H, and lyophilized to obtain Compound (1) in the form of a colorless foam. Yield: 7.04 g, yield: 69%. 300MH2'H-NMR of the ammonium salt of 1 revealed that 1 was a mixture of 3-deoxy-D-glycero-β-ri-tallow and 2-neuraminic acid (20) at a ratio of about 4.3:1.
300MH2’HNMR(DzO)
(1) ・NH,δ: 1.65(18,dd、J=1
1.5Hz、13.0Hz)2.05(18,dd、
J=5.0Hz、 13.0Hz)(20) ・NH,
δ: 1.91(IH,dd、J=3.0Hz、15.
0Hz)2、01 (18,dd、 J=3.OH2,
15,0H2)実施例8((10)−(11)の(1体
〕氷酢酸30mj!に塩化アセチル1Il11を加え、
その中へ水冷上塩化水素ガスを30分間吹き込んだ。さ
らにその中へ化合物(10) 3 g (4,91mm
o 1 )を加え室温にて6時間攪拌した。反応後、微
圧下溶媒を留去し、残渣をシリカゲルカラムクロマトグ
ラフィーにて精製し目的物を得た。300MH2'HNMR (DzO) (1) ・NH, δ: 1.65 (18, dd, J=1
1.5Hz, 13.0Hz) 2.05 (18, dd,
J=5.0Hz, 13.0Hz) (20) ・NH,
δ: 1.91 (IH, dd, J=3.0Hz, 15.
0Hz)2,01 (18,dd, J=3.OH2,
15,0H2) Example 8 ((10)-(11)) Add 1Il11 of acetyl chloride to 30mj of (1 substance) glacial acetic acid,
Hydrogen chloride gas was blown into the water-cooled solution for 30 minutes. Furthermore, compound (10) 3 g (4,91 mm
o 1 ) was added and stirred at room temperature for 6 hours. After the reaction, the solvent was distilled off under slight pressure, and the residue was purified by silica gel column chromatography to obtain the desired product.
収量2.7g 収率94%
質量分析
m/z 386.388 (Mつ
IRスペクトル
2950、1?40.1430.1365 cm−’’
HNMR(300M)lz、 CDCI り2.002
.0? (3HX5. sX5+ C0CHs)2.
24 (IH,dd、 J=14.0. 11.3 H
z、 3−Hax)2.84 (IH,dd、 J−1
4,0,5,0Hz、 3−Heq)4.10 (IH
,dd、 J=12.5.5.0 Hz、 9−H)4
.34 (18,dd、 J=12.5.2.5 Hz
、 9’ −II)4.48 (IH,dd、 J=1
0.5.2.3 Hz、 6−H)4.95 (IH,
t、 J=10.0 Hz、 5−H)5.22 (I
H,m、 8−)1)
5.22 5.34 (IHx2. sX2. CHz
Ph)5.44 (III、 m、 4− H)5.4
7 (IH,dd、 J=8.0.2.3 Hz、 7
−H)7.30 7.40 (5H,cm、 芳香族
H)参考例3((2)→(3)〕
メタノール430慣lに化合物(2)(N−アセチル−
D−ノイラミン酸〕を25 g (84mmol)とD
ohex −50(H”型)50gを加え、80℃で1
0時間加熱環流した。次にDowex −50を濾過し
て除き、微圧下溶媒を留去した。残渣はピリジン100
mj!に溶解し、その中へ無水酢酸22II11とジメ
チルアミノピリジン183mgを加え、室温で7日間攪
拌した。反応後、メタノール50I111を加え、微圧
下溶媒を留去した。残渣はシリカゲルを吸着剤とするカ
ラムクロマトグラフィーにかけ目的物(3)を得た。Yield 2.7 g Yield 94% Mass spectrometry m/z 386.388 (M IR spectrum 2950, 1?40.1430.1365 cm-''
HNMR (300M) lz, CDCI ri 2.002
.. 0? (3HX5. sX5+ C0CHs)2.
24 (IH, dd, J=14.0. 11.3 H
z, 3-Hax) 2.84 (IH, dd, J-1
4,0,5,0Hz, 3-Heq)4.10 (IH
, dd, J=12.5.5.0 Hz, 9-H)4
.. 34 (18, dd, J=12.5.2.5 Hz
, 9'-II) 4.48 (IH, dd, J=1
0.5.2.3 Hz, 6-H)4.95 (IH,
t, J=10.0 Hz, 5-H)5.22 (I
H, m, 8-)1) 5.22 5.34 (IHx2.sX2.CHz
Ph) 5.44 (III, m, 4-H) 5.4
7 (IH, dd, J=8.0.2.3 Hz, 7
-H) 7.30 7.40 (5H, cm, aromatic H) Reference example 3 ((2) → (3)) Compound (2) (N-acetyl-
25 g (84 mmol) of D-neuraminic acid] and D
Add 50g of ohex-50 (H" type) and heat at 80℃ for 1
The mixture was heated under reflux for 0 hours. Next, Dowex-50 was removed by filtration, and the solvent was distilled off under slight pressure. The residue is pyridine 100
mj! 22II11 of acetic anhydride and 183 mg of dimethylaminopyridine were added thereto, and the mixture was stirred at room temperature for 7 days. After the reaction, 50I111 of methanol was added and the solvent was distilled off under slight pressure. The residue was subjected to column chromatography using silica gel as an adsorbent to obtain the desired product (3).
収量8.17 g 収率19%
実施例9((3)→(4)〕
酢酸44t*lに化合物(3)を3.3g(6,5mm
ol)と酢酸ナトリウム5.64gを加え水冷し、その
中へ四酸化二窒素2.1talを酢酸(2mJ! )に
溶解したものを加え室温で2時間攪拌した。反応後、氷
水を加えて過剰の四酸化二窒素を分解し、次に粉末の炭
酸水素ナトリウムを加えて中和した。Yield 8.17 g Yield 19% Example 9 ((3) → (4)) 3.3 g (6.5 mm
ol) and 5.64 g of sodium acetate were added thereto and cooled with water, and 2.1 tal of dinitrogen tetroxide dissolved in acetic acid (2 mJ!) was added thereto and stirred at room temperature for 2 hours. After the reaction, excess dinitrogen tetroxide was decomposed by adding ice water, and then powdered sodium hydrogen carbonate was added to neutralize it.
その水層はジクロロメタン100t*lで3回抽出し、
有機層を合わせて食塩水で洗浄した後、無水硫酸マグネ
シウムで乾燥し、ろ過し、溶媒を留去した。残渣はシリ
カゲルを吸着剤とするカラムクロマトグラフィーにかけ
、目的物(4)を黄色針状晶として得た。The aqueous layer was extracted three times with 100 t*l of dichloromethane,
The organic layers were combined, washed with brine, dried over anhydrous magnesium sulfate, filtered, and the solvent was distilled off. The residue was subjected to column chromatography using silica gel as an adsorbent to obtain the desired product (4) as yellow needles.
収量3.24 g 収率93%
融点 77〜80℃(分解)
質量分析
m/z 534 (M=)
元素分析
計算値 C: 47.19 H: 5.66 N:
5.24測定値 C: 47.20 H: 5.6
1 N: 5.00’HNMR(400MHz、 C
DCj!s)1、80 2.06 (3tl x5.
s x5. C0C)Is)1.78 (IH,dd
、 J=13.0.11.4 Hz、 3−Hax)2
.49 (1)1. dd、 J=13.0.5.3
)1z、 3−)leq)4.05 (18,dd、
J=12.5.6.6 Hz、 9−)1)4.59
(if(、dd、 J=12.5.2.51(z、 9
’ −H)4.74 (IH,t、 J=10.0 H
z、 5−)1)4.91 (1)1. dd、 J=
5.8.2.0 Hz、 ?−H)4.96 (LH,
dd、 J=10.0.2.0 Hz、 6−H)5.
20 (ltl、 m、 8−H)5.59 (LH
,m、 4−t()実施例10((4)→(5)〕
四塩化炭素125mlに化合物(4)を3.14g (
5,9mmol)溶解し、80℃で2時間加熱環流した
。反応後、溶媒を留去し残渣をシリカゲルを吸着剤とす
るカラムクロマトグラフィーにかけ目的物(5)を無色
針状晶として得た。Yield 3.24 g Yield 93% Melting point 77-80°C (decomposition) Mass spectrometry m/z 534 (M=) Elemental analysis calculation C: 47.19 H: 5.66 N:
5.24 Measured value C: 47.20 H: 5.6
1 N: 5.00'HNMR (400MHz, C
DCj! s) 1,80 2.06 (3tl x5.
s x5. C0C) Is) 1.78 (IH, dd
, J=13.0.11.4 Hz, 3-Hax)2
.. 49 (1)1. dd, J=13.0.5.3
)1z, 3-)leq)4.05 (18,dd,
J=12.5.6.6 Hz, 9-)1)4.59
(if(, dd, J=12.5.2.51(z, 9
'-H)4.74 (IH,t, J=10.0H
z, 5-)1)4.91 (1)1. dd, J=
5.8.2.0 Hz, ? -H) 4.96 (LH,
dd, J=10.0.2.0 Hz, 6-H)5.
20 (ltl, m, 8-H)5.59 (LH
, m, 4-t () Example 10 ((4) → (5)) 3.14 g of compound (4) was added to 125 ml of carbon tetrachloride (
5.9 mmol) was dissolved and heated under reflux at 80° C. for 2 hours. After the reaction, the solvent was distilled off and the residue was subjected to column chromatography using silica gel as an adsorbent to obtain the desired product (5) as colorless needle crystals.
収量0.506g 収率17%
融点 115〜118℃
it分析
m/z 507 (M”+ 1)
元素分析
計算値 C: 49.80 H: 5.97測定値
C: 49.90 H: 6.05’HNMR(30
0MHz、 CDC1s>1.83 (1M、 dd、
J=13.0.11.4 Hz、 3−)tax)1
.97−2.12 (3Hx5. SX5.−CD0C
R3)2.51 (IH,dd、 J=13.0.5.
3 Hz、 3−)1eq)3、25 (3H,s、
DC)!3>3、80 (3H,s、 CD0CR
3)4.05 (IH,dd、 J=IO,0,2,
2Hz、 6−1)4.14 (1)1. dd、
J=12.5.6.8 Hz、 9−II)4.7
0 (1)1. dd、 J=12.5. 2.
211z、 9’ −H)4.88 (IH,t、
J=10.0 Hz、 5−H)5.29 (
1)1. m、 8−H)5.30 (IH,m
、 4−H)5.40 (IH,dd、 J=5
.4. 2.2 fiz、 7−H)実施例11 (
(5)−(7))
メタノール2ml!に化合物(5)を48mg(0,0
95mmol)溶解し、その中へ炭酸カリウム6mgを
加え室温で30分間撹拌した。反応後、溶媒を留去し、
残渣をシリカゲルを吸着剤とするカラムクロマトグラフ
ィーに付し、目的物(7)を無色針状晶として得た。Yield 0.506g Yield 17% Melting point 115-118°C IT analysis m/z 507 (M”+ 1) Elemental analysis calculated value C: 49.80 H: 5.97 measured value
C: 49.90 H: 6.05'HNMR (30
0MHz, CDC1s>1.83 (1M, dd,
J=13.0.11.4 Hz, 3-)tax)1
.. 97-2.12 (3Hx5. SX5.-CD0C
R3) 2.51 (IH, dd, J=13.0.5.
3 Hz, 3-)1eq)3,25 (3H,s,
DC)! 3>3,80 (3H,s, CD0CR
3) 4.05 (IH, dd, J=IO, 0, 2,
2Hz, 6-1)4.14 (1)1. dd,
J=12.5.6.8 Hz, 9-II) 4.7
0 (1)1. dd, J=12.5. 2.
211z, 9'-H)4.88 (IH,t,
J=10.0 Hz, 5-H)5.29 (
1)1. m, 8-H) 5.30 (IH, m
, 4-H) 5.40 (IH, dd, J=5
.. 4. 2.2 fiz, 7-H) Example 11 (
(5)-(7)) 2 ml of methanol! 48 mg (0,0
95 mmol) was dissolved therein, 6 mg of potassium carbonate was added thereto, and the mixture was stirred at room temperature for 30 minutes. After the reaction, the solvent was distilled off,
The residue was subjected to column chromatography using silica gel as an adsorbent to obtain the desired product (7) as colorless needle crystals.
収量22mg 収率78%
融点 123〜125℃
質量分析
ra/z 297 (M”+ 1)
元素分析(C1l)l!。o*+ozo)計算値 C:
42.04 H: 7.06測定値 C: 41.
91 H: 6.93’HNMR(300MH2,0
20)
1.65 (18,dd、 J=13.5. 11
.5 Hz、 3−Hax)2.26 (1)1.
dd、 J=13.5. 5.2 )1z、 3
−)1eq)3.19 (3H,s、 −0CR,
)3.49 (IH,t、 J=9.5 Hz、
5−H)3.63 (IH,m、 9−H)3.
73 (1)1. dd、 J=10.0. 0
.8 Hz、 6−H)3.76−3.83 (6)
1. m、 ?−8−9’ −〇及び−COOCR,)Yield 22 mg Yield 78% Melting point 123-125°C Mass spectrometry ra/z 297 (M”+ 1) Elemental analysis (C1l)l!.o*+ozo) Calculated value C:
42.04 H: 7.06 measured value C: 41.
91H: 6.93'HNMR (300MH2,0
20) 1.65 (18, dd, J=13.5. 11
.. 5 Hz, 3-Hax)2.26 (1)1.
dd, J=13.5. 5.2) 1z, 3
-)1eq)3.19 (3H,s, -0CR,
) 3.49 (IH, t, J=9.5 Hz,
5-H) 3.63 (IH, m, 9-H)3.
73 (1)1. dd, J=10.0. 0
.. 8 Hz, 6-H) 3.76-3.83 (6)
1. m, ? -8-9' -○ and -COOCR,)
Claims (1)
D−ガラクト−2−ノヌロピラノソン酸誘導体。 ▲数式、化学式、表等があります▼ (式中R^1は水素又はアセチル基を表わし、R^2は
C_1〜C_6のアルコキシ基、コレステニル基、コレ
スタニル基又はハロゲンを表わし、R^3は水素、C_
1〜C_6のアルキル基、アリール基、アラアルキル基
、アルカリ金属又はNH_4^+を表わす。)[Claims] 3-deoxy-D-glycero- represented by the following general formula
D-galacto-2-nonulopyranosonic acid derivative. ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (In the formula, R^1 represents hydrogen or an acetyl group, R^2 represents a C_1 to C_6 alkoxy group, cholestenyl group, cholestanyl group, or halogen, and R^3 represents hydrogen. , C_
1 to C_6 alkyl group, aryl group, aralkyl group, alkali metal or NH_4^+. )
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22612588A JPH0273093A (en) | 1988-09-09 | 1988-09-09 | 3-deoxy-d-glycero-d-galacto-2-nonulopyranosonic acid derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22612588A JPH0273093A (en) | 1988-09-09 | 1988-09-09 | 3-deoxy-d-glycero-d-galacto-2-nonulopyranosonic acid derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0273093A true JPH0273093A (en) | 1990-03-13 |
Family
ID=16840233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP22612588A Pending JPH0273093A (en) | 1988-09-09 | 1988-09-09 | 3-deoxy-d-glycero-d-galacto-2-nonulopyranosonic acid derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0273093A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007308514A (en) * | 1994-07-20 | 2007-11-29 | Paradigm Biomedical Inc | Immunological activity of rhamnolipid |
-
1988
- 1988-09-09 JP JP22612588A patent/JPH0273093A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007308514A (en) * | 1994-07-20 | 2007-11-29 | Paradigm Biomedical Inc | Immunological activity of rhamnolipid |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kraus et al. | A direct synthesis of C-glycosyl compounds | |
JPS6344590A (en) | Production of sialic acid derivative | |
EP0403150B1 (en) | Process for the preparation of tigogenin beta-cellobioside | |
HU209724B (en) | Process for preparing glucosidase inhibitors and pharmaceutical comp. contg. them | |
JPH0273093A (en) | 3-deoxy-d-glycero-d-galacto-2-nonulopyranosonic acid derivative | |
JP2515568B2 (en) | Novel thiazolidine derivative | |
Knapp et al. | Synthesis of protected aminocyclohexanediols | |
JPH0121146B2 (en) | ||
JPH06508107A (en) | New and improved solvent-free synthesis method of etheric substituted protected monosaccharides and their selective hydrolysis | |
US3445455A (en) | L-lyxopyranosyloxy-alkylcoumarin-containing glycosides | |
Chida et al. | Facile syntheses of some l-sugar derivatives from l-quebrachitol | |
JPS633875B2 (en) | ||
Hung et al. | Efficient Synthesis of 1, 2, 3, 4, 6‐Penta‐O‐acetyl‐l‐idopyranose | |
Hasegawa et al. | Synthesis of 2, 4-diamino-2, 4-dideoxy-L-arabinose derivatives (prumycin derivatives) | |
CN110698523B (en) | Method for chemically synthesizing beta-arbutin | |
TWI744448B (en) | The production method of glycyrrhizic acid and galacturonic acid glycyrrhizic acid and the intermediate used in the production method | |
JPH0269469A (en) | Dihydrofuran derivative and production thereof | |
JP2654680B2 (en) | 3-deoxy-D-glycero-D-galact-2-nonulopyranosonic acid derivative and method for producing the same | |
US3919191A (en) | 14,15{62 -Epoxycardenolide- and 14,15{62 -epoxybufadienolide-glycosides and process for their preparation | |
JPH0372493A (en) | Production of 2'-o-substituted-adenosine-3',5'-cyclic phosphoric acid or its salt | |
CN114644679A (en) | Glucuronic acid glucoside compound, preparation method and application thereof | |
JPS611697A (en) | Novel anthracyclines and manufacture | |
JPS60166680A (en) | Preparation of swainsonine | |
Liang et al. | Efficient Synthesis of Glycosylated Matijin‐Su Derivatives via Ultrasonic Irradiation | |
JPH0543545A (en) | New aza-saccharide derivative |